Gate Crypto Flash News and Market Updates

Gate Flash News covers real-time crypto market updates, Bitcoin and Ethereum price movements, and key industry developments.
Today
13:03
0

BTCS Discloses $64.1M Aave Debt Backed by 46,676 ETH as of November 11

As of November 11, 2026, Nasdaq-listed BTCS disclosed in its latest quarterly filing that it held $64.1 million in outstanding Aave debt backed by 46,676 ETH, after selling holdings below purchase price to manage collateral levels. The company reported $30.6 million in realized losses on digital
More
AAVE-8.10%
ETH-4.15%
12:48
0

17 Countries Condemn Israel's Airstrike on Gaza Hospital on November 14

According to Pakistan's Foreign Ministry statement released on November 14, foreign ministers from 17 countries—including Pakistan, Egypt, Saudi Arabia, Turkey, Jordan, Qatar, United Arab Emirates, Indonesia, Palestine, Algeria, Mauritania, Sudan, Libya, Djibouti, Somalia, Lebanon, and Oman—strongly condemned Israel's airstrike on the Nasser Medical Center in Khan Younis, Gaza.
12:45
0

Erik Voorhees-Linked Wallets Spend $97M to Buy 48,647 ETH in Four Days

According to on-chain monitoring platform Lookonchain, wallets associated with early Bitcoin supporter and ShapeShift founder Erik Voorhees spent $97 million to acquire 48,647 ETH over the past four days, with an average purchase price of $1,994 per token. The tracked wallets currently hold $78.68 million in stablecoins, suggesting potential for further ETH purchases.
ETH-4.15%
12:31
0

CVS Study: GLP-1 Drug Costs Must Drop Below $350/Month for Insurance Cost Recovery

According to CVS Health on November 14, the healthcare group released research suggesting GLP-1 weight-loss medication monthly costs must drop below $350 for insurance plans to achieve cost recovery. Current net costs range from $617 to $766 per person per 30 days, according to the 2025 Employee Benefit Research Institute estimate. CVS tracked approximately 4,000 patients using GLP-1 drugs for three years, finding cumulative medical expenses $9,400 lower than similar non-users, but prescription
More